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Complications after aortic arch hybrid repair
Philipp Geisbüsch, MD,a Drosos Kotelis, MD,a Matthias Müller– Eschner, MD,b
Alexander Hyhlik-Dürr, MD,a and Dittmar Böckler, MD, PhD,a Heidelberg, Germany
Objectives: To analyze early and midterm complications after hybrid aortic arch repair (HAR).
Methods: Between January 1997 and November 2009 among 259 patients receiving thoracic endovascular aortic repair,
HAR has been performed in 47 patients (median age, 64.5 years; range, 41-84). A retrospective analysis was performed.
Complete supra-aortic debranching was performed in 15 patients (32%) and partial debranching in 23 patients (49%).
Isolated left subclavian artery revascularization prior to thoracic endovascular aortic repair has been used in nine patients
(19%). Emergency procedures were performed in 34% of all patients.
Results: The overall in-hospital mortality was 19% (9/47 patients), 27% after complete and 15.6% after partial debranching.
Postoperative complications occurred in 32 patients (68%). Cardiocirculatory complications were observed in seven patients
(15%). Pulmonary complications occurred in 12 patients (26%). A total of five patients (11%) experienced renal complications
requiring hemodialysis. The stroke rate was 6.3%. Paraplegia was seen in three patients (6%). Proximal type I endoleaks were
observed in seven patients. Retrograde aortic arch dissection was seen in three patients (6.3%). Cox proportional hazard
regression showed the necessity for an emergency procedure as an independent predictor of death (hazard ratio, 2.9; 95%
confidence interval, 1.1-7.5; P  .023). The reintervention rate was 27.6% with three patients requiring open conversion.
Conclusions: Hybrid aortic arch repair in high-risk patients is associated with a relevant morbidity, mortality, and
reintervention rate. Patient selection is crucial and indication should be limited to patients not suitable for conventional
aortic arch repair or emergency cases at present. Therefore, we recommend performing HAR only in high-volume centers
with cardiovascular surgical cooperation. (J Vasc Surg 2011;53:935-41.)
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rVascular pathologies, involving the aortic arch, repre-
sent challenging cases for vascular and cardiovascular sur-
geons. Although the constant development of conven-
tional open aortic arch replacement using extracorporal
circulation, selective antegrade cerebral perfusion, and
moderate hypothermia have led to improved results over
years, it is still associated with a relevant morbidity and
mortality rate.1,2 Therefore, especially high-risk surgical
patients may not be suitable candidates for open repair. As
a consequence, thoracic endovascular aortic repair (TEVAR) as a
potentially less invasive treatment has emerged over the last
decade. To extend the proximal landing zone in the aortic
arch, hybrid procedures that provide a sufficient landing
zones and preserve cerebral perfusion are necessary.3 These
hybrid procedures combine an extra-anatomic supra-aortic
debranching with endovascular exclusion of the pathology
and can thus help to avoid sternotomy, single-lung venti-
lation, and aortic cross-clamping. The aortic arch thereby
represents a morphologically challenging region. This is
based on anatomic considerations (eg, proximity of the
supra-aortic vessels, steep angulation of the aortic arch) as
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doi:10.1016/j.jvs.2010.10.053ell as physiologic aspects (vulnerability of the aortic wall,
ulsatile movements of the aorta). Complications of TE-
AR in the aortic arch thus include proximal type I endo-
eckage, retrograde dissection, or stroke. Additionally, the
ecessary rerouting procedures (especially complete supra-
ortic debranching) are associated with a significant mor-
ality and morbidity rate.
The aim of this study was to analyze our results of
ybrid aortic arch repair (HAR) focusing on incidence and
auses of short- and midterm complications.
ETHODS
Patient population. Between January 1997 and No-
ember 2009 among 259 patients receiving TEVAR in our
nstitution, the aortic arch was involved in 101 patients.
ortic arch hybrid procedures have been performed in 47
f these patients (median age, 64.5 years; range, 41-84),
hich represents the total study population. An intention-
o-treat analysis was performed including six patients who
eceived debranching procedures only but no stent graft
lacement for various reasons (explained in detail in the
esults section). Baseline characteristics of all patients are
resented in Table I.
Indications for treatment included 14 patients with a
horacic aortic aneurysm (TAA), 10 patients with a chronic
xpanding aortic dissection (CEAD) type Stanford B, eight
atients with a thoracoabdominal aortic aneurysm (TAAA),
even patients with a penetrating aortic ulcer/intramural
ematoma (IMH), five patients with an acute, complicated
ortic dissection (ADB) type Stanford B, and three patients
ith patch aneurysms/rupture after previous surgical cor-
ection of an aortic coarctation.
Left subclavian artery (LSA) revascularization prior or
imultaneous to TEVAR was only performed in selected
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been published.4
In this study, only patients with prior or simultaneous
LSA revascularization that were initially planned as hybrid
procedures were included. Patients with secondary LSA
revascularization due to arm claudication or subclavian
steal syndrome after TEVAR were excluded.
Procedure. All surgical procedures were performed in
an operation theater equipped with fluoroscopic and angio-
graphic capabilities (Series 9800; OEC Medical Systems,
Inc, Salt Lake City, Utah until April 2007, after that Axiom
U; Siemens, Forchheim, Germany) and a carbon fiber
operating table by a dedicated team of vascular surgeons.
The procedure protocol has been published before.5 All
procedures were performed under general anesthesia, ex-
cept for one patient that received TEVAR under regional
anesthesia. For exact stent graft positioning in the aortic
arch, our treatment concept involves some sort of cardiocir-
culatory arrest, especially in patients with a proximal land-
ing zone 0 to 1. Initially, adenosine-induced cardiac arrest
was used for this purpose and applied in 28 patients. After
experiencing adenosine nonresponse in one patient (hypo-
tonia was used in this patient), we changed to rapid pacing,
which was used in another four patients.
Vascular access to the common femoral artery was
obtained by inguinal cut down in 30 patients, via a Dacron
conduit prosthesis sutured to the left common iliac artery in
nine patients and via an aortic conduit in four patients (3
infrarenal aorta, 1 descending aorta).
Hybrid procedures. Complete supra-aortic vessel
debranching, using a bi-/trifurcated Dacron graft originat-
ing from the ascending aorta to the supra-aortic vessels was
performed in 15 patients (32%). No patient in this cohort
underwent replacement of the ascending aorta. Partial supra-
aortic vessel debranching with carotid–carotid cross-over
bypass was used in 23 patients (49%). Additional revascu-
larization of the left subclavian artery was performed in 16
out of these 23 patients. Isolated left subclavian artery
revascularization via subclavian transposition or carotid–
Table I. Baseline characteristics of all patients with aortic
arch hybrid procedures (n  47)
Age (years) 64 (41-84)
Gender (male) 33 (70)
ASA IIIIV 47 (100)
log Euroscore 31 (5-84)
Hypertension 46 (97)
History of smoking 15 (32)
CHD 19 (40)
Previous myocardial infarction 10 (21)
Renal insufficiency 10 (21)
COPD 17 (36)
Diabetes 5 (11)
Previous aortic surgery 16 (34)
Emergency cases 16 (34)
CHD, Coronary heart disease; COPD, chronic obstructive pulmonary dis-
ease.
Values are presented as median (range) or n (%).subclavian bypass prior to or simultaneous with TEVARhas (een used in nine patients (19%). Additional visceral aortic
ybrid procedures were performed in 6 (5/6 performed
etachronously) out of 47 patients (13%). This includes
hree patients with partial and three patients with complete
upra-aortic debranching. Our experience with visceral hy-
rid procedures has already been published.6,7 Debranch-
ng and staged TEVAR has been performed in 50% of the
atients with a median interval of 27 days (range, 4-126
ays) between debranching and stent graft placement. In
lective cases, we prefer a staged approach and perform an
nterval computed tomographyangiography(CTA)between the
ebranching procedure and TEVAR (Fig 1). Spinal fluid
rainage was used for selected patients at increased risk for
araplegia (eg, long covered aortic segment, previous infra-
enal/thoracic aortic surgery). Neuromonitoring during
ebranching was performed using somatosensory evoked
otentials and transcranial Doppler. Selective shunting was
pplied.
Four different commercially available devices were im-
lanted: 2 TAG/C - TAG (W. L. Gore and Associates,
lagstaff, Ariz), 12 Talent/Valiant (Medtronic Vascular,
anta Rosa, Calif), 3 Endofit (LeMaitre Vascular, Burl-
ngton, Mass), and 3 Zenith (Cook Inc, Bloomington,
nd). Whenever available, stent graft sizing was based on
reoperative centerline measurements.8
Follow-up. The follow-up protocol included postop-
rative CTA before discharge, clinical examination, plain
hest radiography and CTA/MRA 6 and 12 months post-
peratively and annually thereafter. Additionally, duplex
canning to exclude bypass stenosis or occlusion was per-
ormed.Mean follow-up was 21.4months (range, 0.1-96.9
onths) with four patients lost in follow-up (three patients
efused serial aortic imaging and one patient could not be
ocated).
Definitions and statistical analysis. Technical suc-
ess was defined according to the reporting standards for
ndovascular aortic aneurysm repair.9 Endoleaks were
ategorized as described by White, et al10 and specified as
arly endoleaks if apparent on intraoperative control
ngiography or primary postoperative CTA control. Late
ndoleaks were defined as occurring during follow-up.
ulmonary complications were defined as occurrence of
neumonia, pulmonary edema, or necessity for reintuba-
ion/prolonged (2 days) mechanical ventilation. Renal
ailure was considered if temporary or permanent hemo-
ialysis was required.
In patients receiving metachronous procedures, com-
lications related to the debranching procedure were de-
ned as stage I and complications related to TEVAR as
tage II. Complications in patients receiving simultaneous
rocedures were categorized as stage II. Complete deb-
anching was defined as revascularization of at least the
nominate artery and the left carotid artery via bypass from
he ascending aorta. A retrospective analysis of the prospec-
ively collected data was performed. Data are expressed as
ean  SD or median (range). Survival rates were esti-
ated by Kaplan-Meier. Cox proportional hazard model
Cox regression analysis) was used to identify independent
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Volume 53, Number 4 Geisbüsch et al 937risk factors affecting survival. All statistical analyses were
performed using XLSTAT (Version 7.5; Addinsoft SARL,
New York, NY) or MedCalc (Version 9.5.2; MedCalc
software, Mariakerke, Belgium).
RESULTS
Early outcomes
Mortality. The overall in-hospital mortality was 19%
(9/47 patients), 27% (4/15 patients) after complete deb-
ranching, and 15.6% (5/32 patients) after partial debranch-
ing. Causes of death in these nine patients were multiorgan
failure in three patients (Table II). Lethal intracerebral
hemorrhage (ICB) was observed in two patients, including
Fig 1. Three-dimensional volume rendering of compu
chronic expanding aortic dissection type B (entry tear: wh
debranching (white arrows).
Table II. In-hospital mortality of all patients with aortic a
Total
(n  47)
Complete deb
(n  1
Mortality stage I 4 (6.3%) 3 (20%
Causes of death
Myocardial infarction 1
Pneumonia 1
Stroke —
Unknown 1
Mortality stage II 5 (10.6%) 1 (6.6
Causes of death
Multiorgan failure 1
ICB —
In-hospital mortality 9 (19%) 4 (27%
ICB, Intracerebral hemorrhage.one patient with an ICB on day 11 after partial debranching tnd TEVAR (initial postoperative uneventful), and one
atient with a cerebellar hemorrhage on day 25 after open
onversion due to intraoperative retrograde aortic arch
issection.
A total of 4/47 patients (6.3%) died after supra-
ortic debranching before staged, planed TEVAR could
e performed. Causes of death included pneumonia,
troke, and myocardial infarction. One patient died un-
xpectedly on the second postoperative day after com-
lete debranching (initial postoperative course com-
letely uneventful). The actual cause of death remained
nclear since an autopsy was denied by the relatives.
Elective vs emergency procedures. Results for elec-
omography angiographies showing a (A) preoperative
row) and (B) retrograde type A dissection after complete
ybrid procedures (n  47)
ing Partial debranching
(n  32)
Arch and visceral hybrid
procedures (n  6)
1 (3.1%)
—
—
1
—
3 (9.3%) 1 (16.6%)
1 1
2 —
5 (15.6%) 1 (16.6%)ted t
ite arrch h
ranch
5)
)
%)
)ive versus emergency procedures are shown in Table III.
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for an emergency procedure as an independent predictor of
death. A complete debranching procedure did not influ-
ence survival in this series (Table IV).
Morbidity. Postoperative complications occurred in
32 patients (68%), with five patients experiencing isolated
minor (wound/lymphatic) complications.
Complications stage I (Table V). A total of eight pa-
tients (17%) experienced complications at this stage of the
procedure. The majority of complications (7/8 patients)
occurred after complete debranching and included cardiac
(myocardial infarction, hemodynamic relevant arrhythmia
requiring electrical cardioversion, temporary cardiocircula-
tory arrest) and pulmonary complications. Stroke with a
consecutive lethal cerebral edema was observed in one
patient after partial debranching. One patient developed an
acute-on-chronic renal failure and required temporary he-
modialysis. Retrograde dissection was observed in one pa-
tient (see retrograde dissection section below).
Complications stage II (Table V). A total of 24 pa-
tients (51%) experienced complications at this stage of the
procedure, with an increasing incidence from complete
(33%) to partial (47%) to combined arch and visceral hybrid
procedures (67%). Cardiac complications includedmyocar-
dial infarction, hypertensive crisis (consecutive temporary
left heart failure with pulmonary edema), and temporary
cardiocirculatory arrest (two patients). Renal complications
were observed in five patients, including three patients with
combined visceral/aortic arch hybrid procedures showing
renal failure after visceral debranching (1 permanent he-
modialysis) and two patients with a temporary acute renal
failure. Perioperative stroke occurred in two patients after
simultaneous partial debranching and TEVAR. Lethal in-
tracerebral hemorrhage was seen in two patients (described
above). Permanent paraplegia was observed in three pa-
tients (6%). This was related to an acute, complicated
(paraplegia) aortic dissection type Stanford B in one pa-
tient. One patient showed paraplegia after emergency con-
Table III. In-hospital mortality of emergency (n  16)
vs elective (n  31) aortic arch hybrid procedures
Variable
Complete
debranching
Partial
debranching Total
Emergency 2/4 (50%) 3/12 (25%) 5/16 (31%)
Elective 2/11 (18%) 2/20 (10%) 4/31 (13%)
Table IV. Risk factor analysis regarding perioperative
death (Cox regression analysis)
Variable Hazard ratio 95% CI P value
Emergency procedure 2.9 1.1-7.5 .023
Complete debranching 1.58 0.59-4.2 .361
CI, Confidence interval.version due to a retrograde dissection, and one patient tuffered paraplegia after simultaneous visceral and arch
ybrid procedure.
Endoleaks. Proximal type I endoleaks were observed in
even patients (6 primary endoleaks, 1 secondary en-
oleak). Six out of these seven patients received a reinter-
ention (4 further debranching and proximal stent graft
xtension, 2 proximal stent graft extension) that sealed
he endoleaks in five patients. One patient showed a small,
ersistent type Ia endoleak despite stent graft extension.
he patient has been under close CTA surveillance for 3
ears without signs of expansion. One out of seven patients
as referred for open conversion since the endoprosthesis
ould not be placed more proximally in the aortic arch due
o a heavy angulation of the aortic arch, but open conver-
ion was denied in this high-risk patient. An endoleak type
I was observed in four patients (3 LSA, 1 bronchial
rtery), which spontaneously sealed in two patients. One
atient received a subclavian transposition and one patient
s under CTA control.
Retrograde aortic dissection. Retrograde aortic dissec-
ion was observed in three patients (6.3%). One patient (50
ears, chronic expanding type B aortic dissection) showed a
etrograde aortic dissection after complete aortic arch deb-
anching on the first postoperative CTA11 (Fig 1). There-
ore, TEVAR was denied and open aortic arch replacement
sing the frozen elephant trunk technique was performed.
he postoperative course was uneventful. Retrospectively,
clamp injury at the ascending aorta with resulting dissec-
ion was the suspected reason. The second patient (65
ears, chronic expanding type B aortic dissection) experi-
nced an intraoperative retrograde aortic dissection during
EVAR. The patient initially had received subclavian trans-
osition prior to the endograft placement. During TEVAR,
proximal dislocation of the endoprosthesis with partial
overage of the left common carotid artery occurred, and a
tent graft placement in chimney technique as a bailout
rocedure was attempted. During this procedure, a retro-
rade dissection in the ascending aorta, possibly related to
he wire manipulation, was visualized on transesophageal
chocardiography. The patient underwent immediate open
onversion. Intraoperatively, partial occlusion of the left
ommon carotid artery by the endograft was verified. Dur-
ng the postoperative course, the patient experienced para-
legia and died of an intracerebral hemorrhage, possibly
elated to cerebrospinal fluid drainage. During follow-up, a
hird patient (64 years, chronic expanding type B aortic
issection) experienced retrograde aortic dissection in the
roximal aortic arch with a major stroke 5 years after partial
ebranching and TEVAR. The patient was denied open
rch repair and died in the sequel of this persistent neuro-
ogical deficit.
Bypass occlusion. No early bypass occlusion was ob-
erved. During follow-up, one patient developed an asymp-
omatic, retrosternal compression of an ascending carotid
left common carotid artery) bypass 2 years after complete
ebranching (Fig 2). Bypass correction with carotid–
arotid cross-over bypass was performed. A second pa-
ient experienced an asymptomatic bypass occlusion of a
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nal carotid artery via cross-flow. A new carotid–carotid
cross-over bypass was performed.
Intention to treat
The hybrid procedure could not be completed in six
Table V. Early and midterm complications of all patients
Total (n  47)
Comp
Morbidity stage I 8 (17%)
Cardiac complications 3
Pulmonary complications 2
Renal failure 1
Stroke 1
Retrograde dissection 1
Morbidity stage II 24 (51%)
Cardiac complications 4
Pulmonary complications 10
Renal failure 5
Stroke 2
ICB 2
Paraplegia 3
Retrograde dissection 1
Wound/lymphatic complication 5
Primary type IA endoleak 6 (13%)
In-hospital morbidity 32 (68%)
Midterm complications
Retrograde dissection —
Bypass stenosis/occlusion —
ICB, Intracerebral hemorrhage.
Fig 2. Control computed tomography angiography showing a
retrosternal bypass compression (white arrow) 2 years after com-
plete debranching.patients, which includes three patients that died after the rebranching procedure and one patient that experienced a
etrograde dissection after complete rerouting and received
pen conversion. Two patients showed an extremely
inked aorta with a steep aortic arch and we were not able
o deliver the endograft into the aortic arch despite an
dditional brachial access. One patient (50 years, pseudo-
neurysm after surgical correction of an aortic coarctation)
eceived conventional aortic arch repair and is currently
live 2 years after the operation. The second patient was
enied open repair and died 8 months after the failed
ybrid repair for unknown reason.
ate outcomes
The Kaplan-Meier survival estimates at 1 and 3 years
ere 77% 6% and 59% 8%, respectively (Fig 3). Causes
f late death were stroke/intracerebral hemorrhage in three
atients, myocardial infarction in one patient, and pneumo-
ia in one patient. Aortic-related death occurred in two
atients. One 81-year-old patient died of an ascending
ortic rupture two and a half years postoperatively after a
uccessful aortic arch hybrid procedure for a TAA. Open
ardiac surgery with replacement of the ascending aorta was
enied in this highly comorbid patient. One patient died of
retrograde aortic dissection (described above). One pa-
ient died of an unknown reason 8 months postoperatively.
he overall reintervention rate was 27.6% (13 patients)
ith three patients (6.3%) requiring open conversion.
ISCUSSION
The present series shows thatHAR, especially complete
ebranching procedures, is associated with a relevant mor-
ality rate (19%). The analysis further revealed severe com-
lications in a significant proportion of patients causing
aortic arch hybrid procedures (n  47)
ebranching
15)
Partial debranching
(n  32)
Arch and visceral hybrid
procedures (n  6)
7%) 1 (3%) —
— —
— —
— —
1 —
— —
3%) 15 (47%) 4 (67%)
2 —
7 1
1 3
1 1
2 —
2 1
1 —
2 —
5 (17%) 1 (17%)
0%) 16 (50%) 4 (67%)
— 1
2 —with
lete d
(n 
7 (4
3
2
1
—
1
5 (3
2
2
1
—
—
—
—
3
—
12 (8
—
—eintervention in approximately 25% of all patients.
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April 2011940 Geisbüsch et alThe reported mortality rates after aortic arch hybrid
procedures vary between 0% and 15.4% and are thus below
our mortality rate.12-17 A possible explanation could be
significant differences in patient selection. At present, all
series limit patient selection for hybrid procedures to high-
risk patients “unfit” or “not suitable” for open aortic arch
repair but definition of “high-risk” and comparable selec-
tion criteria of these patients (eg, Risc scores) are frequently
missing. Czerny et al report a log Euroscore of 26 (range,
12-56) in their series of 27 patients with aortic arch hybrid
repair that seems comparable to our series.18 Their mortal-
ity rate of 7.4% is favorable to our results, but again, patient
selection warrants attention. No emergency cases were
included in their series (all stent grafts placed metachro-
nously) compared with 34% emergency procedures in our
series, which influenced perioperative survival (hazard ra-
tio, 2.9; P .023) Additionally, the underlying pathologies
(eg, the percentage of acute, complicated type B dissection)
and the amount (17%-60%) of complete debranching pro-
cedures (32% in this series) vary significantly and make
comparison of the few available larger series difficult. In this
series, complete debranching procedures showed a higher
mortality rate (27% vs 15.6%), although this did not reach
statistical significance (P .36), possibly caused by the still
relatively small amount of patients. Our patient selection
initially involved only “high-risk patients” for hybrid pro-
cedures, but we expanded our indications after early prom-
ising results.3,19 At present, after experiencing serious com-
plications in a viable amount of patients as described in this
series, a very strict (meaning not suitable/denied for open
repair) patient selection has been restored. At present,
approximately 60% of aortic arch hybrid procedures are
performed simultaneously and no evidence-based recom-
mendation regarding temporal tactics exist so far.20,21We prefer
a staged approach in elective cases, but due to the small
numbers in both groups (simultaneous vs staged), a valu-
Fig 3. Kaplan-Meier survival analysis of all patients (n  47)
treated with aortic arch hybrid procedures.able comparison regarding outcome is questionable, espe- aially as all simultaneously performed emergency cases
which showed a worse outcome) could bias this analysis.
Retrograde aortic dissection was observed in a signifi-
ant proportion of patients (6.3%) in this series. This is
bove the reported incidence of 1.3% after TEVAR, but
xplicable as the analysis from the “European registry on
ndovascular aortic repair complications” included TEVAR
n all aortic segments.22 Reasons for this complication in
ur series (three patients) included clamp damage at the
scending aorta during complete debranching, stiff guidewire/
ose cone manipulation in the aortic arch and disease
rogression. The underlying pathology was a type B dissec-
ion in all cases, which is in line with Eggebrecht et al who
howed these patients to be most prone for the occurrence
f retrograde dissection.22 Management of this complica-
ion consists of urgent open surgical conversion, which
akes cardiosurgical back-up for aortic arch hybrid proce-
ures in our opinion inevitable.
Delivery of the stent graft into the aortic arch, and thus
ompletion of the hybrid procedure, was not possible in
wo cases in this series due to a heavily kinked aorta with a
teep arch angulation. A possible solution for this problem
ncludes an additional transbrachial access or antegrade
eployment, which both failed in these cases. In our expe-
ience, especially young patients with previous open aortic
rch surgery (eg, for aortic coarctation) present with this
hallenging anatomy and warrant special considerations.
Stroke rates after arch hybrid repair vary between 0%
nd 8% in the literature and are thus in line with the stroke
ate of 6.3% in this study.14,23 Reasons for stroke include
lamping/embolism formation during the rerouting pro-
edure or manipulation in the diseased aortic arch during
EVAR. The incidence of spinal cord injury after isolated
ortic arch hybrid procedure is low (0%-4%).23,24 Fre-
uently, the reported cases of paraplegia are associated with
concomitant visceral hybrid procedure and long covered
ortic segment, as also seen in our series.25
Bypass occlusion/stenosis is a rare, but described com-
lication and occurred in two patients in this series. We
herefore perform routine bypass duplex ultrasound during
ollow-up.
The Achilles’ heel of endografting in the aortic arch
emains the development of proximal type I endoleaks with
reported incidence of 0%-25% (15% in this series) leading
o further reinterventions.14,15,24,26 Reasons include a
hort landing zone (2 cm), which might have been ac-
epted in a first approach (especially emergency cases) to
void sternotomy and complete debranching in these high-
isk patients. In our series, 5/6 proximal type I endoleaks
ere seen after partial debranching and 4/6 were sealed
ith further debranching and proximal stent graft exten-
ion. Additionally, the recently available stent grafts are not
esigned especially for the aortic arch and miss conform-
bility at the inner curve (bird beak sign). This is especially
revalent in patients with a steep aortic arch and the mid-
ortic arch section.
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Volume 53, Number 4 Geisbüsch et al 941CONCLUSION
Aortic arch hybrid procedures show a variety of severe
complications associated with a relevant morbidity, mortal-
ity, and reintervention rate and should therefore only be
performed in high-volume centers with cardiosurgical
back-up. Patient selection is crucial in these cases and
indication should be limited to patients not suitable for
conventional aortic arch repair. Off-the-shelf, single-
branched endoprosthesis may represent the future solution
in the aortic arch to avoid complete debranching and
possibly reduce morbidity and mortality of HAR.
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